Arcoma AB (Sweden) Price on December 4, 2024
ARCOMA Stock | SEK 10.60 0.05 0.47% |
If you're considering investing in Arcoma Stock, it is important to understand the factors that can impact its price. As of today, the current price of Arcoma AB stands at 10.60, as last reported on the 11th of December 2024, with the highest price reaching 10.80 and the lowest price hitting 10.45 during the day. Arcoma AB secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15% return per unit of standard deviation over the last 3 months. Arcoma AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arcoma AB's risk adjusted performance of (0.10), and Mean Deviation of 1.83 to double-check the risk estimate we provide.
Arcoma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Arcoma |
Sharpe Ratio = -0.1525
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ARCOMA |
Estimated Market Risk
2.84 actual daily | 25 75% of assets are more volatile |
Expected Return
-0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arcoma AB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcoma AB by adding Arcoma AB to a well-diversified portfolio.
Arcoma AB Valuation on December 4, 2024
It is possible to determine the worth of Arcoma AB on a given historical date. On December 4, 2024 Arcoma was worth 10.95 at the beginning of the trading date compared to the closed value of 10.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arcoma AB stock. Still, in general, we apply an absolute valuation method to find Arcoma AB's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcoma AB where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arcoma AB's related companies.
Open | High | Low | Close | Volume | |
10.60 | 11.30 | 10.60 | 10.95 | 68,252 | |
12/04/2024 | 10.95 | 11.30 | 10.80 | 10.95 | 24,527 |
10.90 | 11.15 | 10.75 | 11.10 | 21,943 |
Backtest Arcoma AB | | | Arcoma AB History | | | Arcoma AB Valuation | Previous | Next |
Arcoma AB Trading Date Momentum on December 4, 2024
On December 05 2024 Arcoma AB was traded for 11.10 at the closing time. The highest price during the trading period was 11.15 and the lowest recorded bid was listed for 10.75 . The volume for the day was 21.9 K. This history from December 5, 2024 contributed to the next trading day price jump. The overall trading delta to the next closing price was 1.37% . The overall trading delta to the current price is 2.28% . |
Arcoma AB Fundamentals Correlations and Trends
By evaluating Arcoma AB's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arcoma AB's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arcoma financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arcoma AB Stock history
Arcoma AB investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcoma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcoma AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcoma AB stock prices may prove useful in developing a viable investing in Arcoma AB
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscleskeleton, thoratic, pediatric, and traumaresus clinics. Arcoma AB is traded on Stockholm Stock Exchange in Sweden.
Arcoma AB Stock Technical Analysis
Arcoma AB technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arcoma AB Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Arcoma AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arcoma AB December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Arcoma AB stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcoma AB shares will generate the highest return on investment. By undertsting and applying Arcoma AB stock market strength indicators, traders can identify Arcoma AB entry and exit signals to maximize returns
Arcoma AB Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcoma AB's price direction in advance. Along with the technical and fundamental analysis of Arcoma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcoma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.10) | |||
Jensen Alpha | (0.51) | |||
Total Risk Alpha | (0.90) | |||
Treynor Ratio | (0.87) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Arcoma Stock analysis
When running Arcoma AB's price analysis, check to measure Arcoma AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcoma AB is operating at the current time. Most of Arcoma AB's value examination focuses on studying past and present price action to predict the probability of Arcoma AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcoma AB's price. Additionally, you may evaluate how the addition of Arcoma AB to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |